Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

RPE65 c.393T>A, p.(Asn131Lys): Novel Sequence Variant Detected (CROSBI ID 312383)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bjeloš, Mirjana ; Bušić, Mladen ; Ćurić, Ana ; Bosnar, Damir ; Šarić, Borna ; Marković, Leon ; Elabjer, Biljana Kuzmanović ; Rak, Benedict RPE65 c.393T>A, p.(Asn131Lys): Novel Sequence Variant Detected // Case reports in ophthalmological medicine, 2022 (2022), 1-4. doi: 10.1155/2022/5710080

Podaci o odgovornosti

Bjeloš, Mirjana ; Bušić, Mladen ; Ćurić, Ana ; Bosnar, Damir ; Šarić, Borna ; Marković, Leon ; Elabjer, Biljana Kuzmanović ; Rak, Benedict

engleski

RPE65 c.393T>A, p.(Asn131Lys): Novel Sequence Variant Detected

Background. Leber congenital amaurosis (LCA) is a monogenic, but genetically heterogenous disease, and at least 27 genes are implicated. This case report is aimed at providing evidence to link the novel variant RPE65 c.393T>A, p.(Asn131Lys), variant of uncertain significance (VUS), to clinical phenotype and to set the ground for objective assignment of pathogenicity confidence. Case Presentation. A case report of a female patient with LCA who manifested with nystagmus, night blindness, profound visual deficiency, and peripheral involvement of the retina consistent with RPE65 dystrophy. A thorough clinical examination, diagnostic evaluation, and genetic testing were performed. The patient was a compound heterozygote in trans form: RPE65 c.304G>T, p.(Glu102) pathogenic, and RPE65 c.393T>A, p.(Asn131Lys), VUS. The latter variant is absent in healthy controls and is considered harmful on in silico prediction. Conclusions. We conclude that RPE65 c.393T>A, p. (Asn131Lys) contributed to the pathologic phenotype, demonstrating its significance clearly in the case presented, and should be reclassified according to the criteria of evidence as likely pathogenic. This being the case, patients with this specific variant are likely candidates for genetic treatment.

genes ; mutation ; retinitis pigmentosa ; night blindness ; photoreceptor cells

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

2022

2022.

1-4

objavljeno

2090-6730

10.1155/2022/5710080

Povezanost rada

nije evidentirano

Poveznice